Northern Trust
CDLX icon

Northern Trust’s Cardlytics CDLX Stock Holding History

Northern Trust’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$114K Sell
10,846
-335
-3% -$3.27K ﹤0.01% 4069
2025
Q4 		$129K Sell
11,181
-147
-1% -$2.27K ﹤0.01% 4085
2025
Q3 		$275K Sell
11,328
-237
-2% -$3.95K ﹤0.01% 3862
2025
Q2 		$190K Sell
11,565
-25,001
-68% -$432K ﹤0.01% 3955
2025
Q1 		$665K Sell
36,566
-811
-2% -$23.2K ﹤0.01% 3454
2024
Q4 		$1.39M Buy
37,377
+2,754
+8% +$105K ﹤0.01% 3228
2024
Q3 		$1.11M Buy
34,623
+2,934
+9% +$163K ﹤0.01% 3319
2024
Q2 		$2.6M Buy
31,689
+287
+0.9% +$31K ﹤0.01% 2761
2024
Q1 		$4.55M Sell
31,402
-616
-2% -$52K ﹤0.01% 2525
2023
Q4 		$2.95M Buy
32,018
+3,768
+13% +$383K ﹤0.01% 2783
2023
Q3 		$4.66M Buy
28,250
+1,359
+5% +$177K ﹤0.01% 2482
2023
Q2 		$1.7M Buy
26,891
+749
+3% +$45.4K ﹤0.01% 3096
2023
Q1 		$888K Sell
26,142
-2,106
-7% -$110K ﹤0.01% 3256
2022
Q4 		$1.63M Sell
28,248
-1,090
-4% -$67.3K ﹤0.01% 3096
2022
Q3 		$2.76M Sell
29,338
-1,253
-4% -$178K ﹤0.01% 2834
2022
Q2 		$6.83M Sell
30,591
-413
-1% -$138K ﹤0.01% 2301
2022
Q1 		$17M Sell
31,004
-1,282
-4% -$775K ﹤0.01% 1786
2021
Q4 		$21.3M Sell
32,286
-34
-0.1% -$26K ﹤0.01% 1723
2021
Q3 		$27.1M Sell
32,320
-2,755
-8% -$2.79M ﹤0.01% 1567
2021
Q2 		$44.5M Buy
35,075
+731
+2% +$825K 0.01% 1224
2021
Q1 		$37.7M Buy
34,344
+2,066
+6% +$2.73M 0.01% 1348
2020
Q4 		$46.1M Sell
32,278
-920
-3% -$981K 0.01% 1135
2020
Q3 		$23.4M Sell
33,198
-395
-1% -$287K 0.01% 1506
2020
Q2 		$23.5M Buy
33,593
+14,110
+72% +$8.15M 0.01% 1478
2020
Q1 		$6.81M Buy
19,483
+314
+2% +$222K ﹤0.01% 2126
2019
Q4 		$12.1M Buy
19,169
+2,371
+14% +$1.16M ﹤0.01% 2060
2019
Q3 		$5.63M Buy
16,798
+7,034
+72% +$2.26M ﹤0.01% 2481
2019
Q2 		$2.54M Buy
9,764
+2,211
+29% +$443K ﹤0.01% 2938
2019
Q1 		$1.25M Buy
7,553
+74
+1% +$12K ﹤0.01% 3289
2018
Q4 		$810K Sell
7,479
-789
-10% -$133K ﹤0.01% 3429
2018
Q3 		$2.07M Buy
8,268
+1,342
+19% +$289K ﹤0.01% 3190
2018
Q2 		$1.51M Buy
6,926
+1,190
+21% +$220K ﹤0.01% 3341
2018
Q1 		$840K Buy
+5,736
New +$970K ﹤0.01% 3430

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Northern Trust's CDLX Position: Q1 2026 in Review

Northern Trust reduced its Cardlytics (CDLX) stake by 3% in Q1 2026, selling an estimated $3.27K and leaving 10,846 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #4069.

Northern Trust first reported a position in CDLX in Q1 2018 and has held it in 33 quarters since. The position peaked at $46.1M in Q4 2020. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Northern Trust held 10,846 shares of Cardlytics worth $114K as of Q1 2026.
  • Northern Trust sold 335 Cardlytics shares in Q1 2026, an estimated $3.27K.
  • Cardlytics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4069 holding.
  • Northern Trust first reported a position in Cardlytics in Q1 2018 and has held it in 33 quarters since.
  • Northern Trust's Cardlytics position peaked at $46.1M in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.